Acelyrin, Inc Common Stock Buy Hold or Sell Recommendation
| SLRN Stock | USD 4.55 0.02 0.44% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding ACELYRIN, INC Common is 'Cautious Hold'. The recommendation algorithm takes into account all of ACELYRIN, INC's available fundamental, technical, and predictive indicators you will find on this site.
Check out ACELYRIN, INC Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as ACELYRIN, and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
ACELYRIN, |
Execute ACELYRIN, INC Buy or Sell Advice
The ACELYRIN, recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ACELYRIN, INC Common. Macroaxis does not own or have any residual interests in ACELYRIN, INC Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ACELYRIN, INC's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ACELYRIN, INC Trading Alerts and Improvement Suggestions
| ACELYRIN, INC Common had very high historical volatility over the last 90 days | |
| ACELYRIN, INC Common has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (381.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ACELYRIN, INC generates negative cash flow from operations | |
| ACELYRIN, INC Common has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Murugan Amar of 525000 shares of ACELYRIN, INC at 4.73 subject to Rule 16b-3 |
ACELYRIN, INC Returns Distribution Density
The distribution of ACELYRIN, INC's historical returns is an attempt to chart the uncertainty of ACELYRIN, INC's future price movements. The chart of the probability distribution of ACELYRIN, INC daily returns describes the distribution of returns around its average expected value. We use ACELYRIN, INC Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ACELYRIN, INC returns is essential to provide solid investment advice for ACELYRIN, INC.
| Mean Return | -0.02 | Value At Risk | -8.3 | Potential Upside | 8.55 | Standard Deviation | 5.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ACELYRIN, INC historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ACELYRIN, INC Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ACELYRIN, INC or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ACELYRIN, INC's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ACELYRIN, stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 2.15 | |
σ | Overall volatility | 5.14 | |
Ir | Information ratio | -0.03 |
ACELYRIN, INC Volatility Alert
ACELYRIN, INC Common exhibits very low volatility with skewness of 0.42 and kurtosis of 1.77. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ACELYRIN, INC's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ACELYRIN, INC's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ACELYRIN, INC Fundamentals Vs Peers
Comparing ACELYRIN, INC's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ACELYRIN, INC's direct or indirect competition across all of the common fundamentals between ACELYRIN, INC and the related equities. This way, we can detect undervalued stocks with similar characteristics as ACELYRIN, INC or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ACELYRIN, INC's fundamental indicators could also be used in its relative valuation, which is a method of valuing ACELYRIN, INC by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ACELYRIN, INC to competition |
| Fundamentals | ACELYRIN, INC | Peer Average |
| Return On Equity | -0.42 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Current Valuation | (97.33 M) | 16.62 B |
| Shares Outstanding | 100.33 M | 571.82 M |
| Shares Owned By Insiders | 8.00 % | 10.09 % |
| Shares Owned By Institutions | 99.48 % | 39.21 % |
| Number Of Shares Shorted | 5.73 M | 4.71 M |
| Price To Book | 0.87 X | 9.51 X |
| EBITDA | (381.53 M) | 3.9 B |
| Net Income | (381.64 M) | 570.98 M |
| Total Debt | 1.19 M | 5.32 B |
| Book Value Per Share | 5.29 X | 1.93 K |
| Cash Flow From Operations | (169.71 M) | 971.22 M |
| Short Ratio | 10.10 X | 4.00 X |
| Earnings Per Share | (2.46) X | 3.12 X |
| Target Price | 11.17 | |
| Number Of Employees | 135 | 18.84 K |
| Market Capitalization | 458.49 M | 19.03 B |
| Total Asset | 742.69 M | 29.47 B |
| Retained Earnings | (488.72 M) | 9.33 B |
| Working Capital | 651.48 M | 1.48 B |
| Net Asset | 742.69 M |
Note: Acquisition by Murugan Amar of 525000 shares of ACELYRIN, INC at 4.73 subject to Rule 16b-3 [view details]
ACELYRIN, INC Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ACELYRIN, . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 7035.65 | |||
| Daily Balance Of Power | (0.11) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 4.59 | |||
| Day Typical Price | 4.58 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (0.02) |
About ACELYRIN, INC Buy or Sell Advice
When is the right time to buy or sell ACELYRIN, INC Common? Buying financial instruments such as ACELYRIN, Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ACELYRIN, INC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Printing and Publishing Thematic Idea Now
Printing and Publishing
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ACELYRIN, INC Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Return On Assets (0.33) | Return On Equity (0.42) |
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.